SCHEMBL97104

SCHEMBL97104

[CH]=C/C=C/C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL956907 0.96
SCHEMBL816547 0.96
SCHEMBL579028 0.96
SCHEMBL137814 0.96
SCHEMBL817679 0.96
SCHEMBL820235 0.96
SCHEMBL956908 0.96
SCHEMBL814800 0.96
SCHEMBL1853841 0.96
SCHEMBL814880 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2586 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114684815-A Method for repairing structural defects of graphene 南通普朗克石墨烯科技有限公司 2022-07-01 CN claimed
EP-3191482-B1 1,2,3-THIADIAZOL-5YL-UREA DERIVATIVES, USE THEREOF FOR REGULATING PLANT SENESCENCE AND PREPARATIONS CONTAINING THESE DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-03-27 EP claimed
US-20080176858-A1 SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS ADENOSINE THERAPEUTICS, LLC (US) 2008-07-24 US claimed
US-7288548-B2 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA, INC. (CA) 2007-10-30 US claimed
US-20070244134-A1 Selective antagonists of A2A adenosine receptors ADENOSINE THERAPEUTICS, LLC 2007-10-18 US claimed
US-7217702-B2 Selective antagonists of A2A adenosine receptors ADENOSINE THERAPEUTICS, LLC (US) 2007-05-15 US claimed
US-20050176767-A1 Pyridine carboxamide and methods for inhibiting HIV integrase VIRO CHEM PHARMA, INC. (CA) 2005-08-11 US claimed
US-20050171078-A1 Novel azacyclic ethynyl derivatives NEUROSEARCH (DK) 2005-08-04 US claimed
WO-2005042524-A1 PYRIDINE CARBOXAMIDE AND METHODS FOR INHIBITING HIV INTEGRASE VIROCHEM PHARMA INC. (CA) 2005-05-12 WO claimed
US-6005113-A FLUORESCENT DIBENZOPYRROMETHENEBORON DIFLUORIDE DYES FOR TRACING TRANSPORT WITHIN A SAMPLE MOLECULAR PROBES, INC. (US) 1999-12-21 US claimed
EP-0612336-B1 LONG WAVELENGTH CHEMICALLY REACTIVE DIPYRROMETHENEBORON DIFLUORIDE DYES AND CONJUGATES MOLECULAR PROBES INC (US) 1998-01-07 EP claimed
US-5451663-A Fluorescent dyes MOLECULAR PROBES, INC. (US) 1995-09-19 US claimed
EP-0612336-A1 LONG WAVELENGTH CHEMICALLY REACTIVE DIPYRROMETHENEBORON DIFLUORIDE DYES AND CONJUGATES MOLECULAR PROBES, INC. (US) 1994-08-31 EP claimed
US-5274113-A Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates MOLECULAR PROBES, INC. (US) 1993-12-28 US claimed
WO-1993009185-A1 LONG WAVELENGTH CHEMICALLY REACTIVE DIPYRROMETHENEBORON DIFLUORIDE DYES AND CONJUGATES MOLECULAR PROBES, INC. (US) 1993-05-13 WO claimed
US-4568483-A CATIONIC COPOLYMERS WITH HETEROCYCLIC COMONOMERS, MECHANICAL PROPEETIES BASF AKTIENGESELLSCHAFT (DE) 1986-02-04 US claimed
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders INMED PHARMACEUTICALS INC. 2024-07-23 US disclosed
US-20240239751-A1 PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF BRIDGEBIO GENE THERAPY RESEARCH, INC. 2024-07-18 US disclosed
US-4060417-A Diffusion transfer elements comprising color-providing compounds capable of cleavage upon reaction with silver ions and silver ion barrier layers POLAROID CORPORATION (US) 1977-11-29 US disclosed
US-3971825-A (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS SANKYO COMPANY LIMITED (JA) 1976-07-27 US disclosed